Development of anti-‐Leishmaniavaccines…
261
54 Carmelo, E.; Zurita, A. I.; Martinez, E.; Valladares, B. The sera from individuals suffering
from cutaneous leishmaniasis due to
Leishmania brazilensis
present antibodies against
parasitic conserved proteins, but not their human counterparts. Parasite
13
, 231-‐236
(2006).
55 Carmelo, E.; Martinez, E.; Gonzalez, A. C.; Pinero, J. E.; Patarroyo, M. E.; Del Castillo, A.;
Valladares, B. Antigenicity of
Leishmania braziliensis
histone H1 during cutaneous
leishmaniasis: localization of antigenic determinants. Clinical and Diagnostic Laboratory
Immunology
9
, 808-‐811(2002).
56 Soto, M.; Requena, J. M.; Quijada, L.; Garcia, M.; Guzman, F.; Patarroyo, M. E.; Alonso, C.
Mapping of the linear antigenic determinants from the
Leishmania infantum
histone H2A
recognized by sera from dogs with leishmaniasis. Immunology Letters
48
, 209-‐214
(1995).
57 Soto, M.; Requena, J. M.; Quijada, L.; Gomez, L. C.; Guzman, F.; Patarroyo, M. E.; Alonso, C.
Characterization of the antigenic determinants of the
Leishmania infantum
histone H3
recognized by antibodies elicited during canine visceral leishmaniasis. Clinical and
Experimental Immunology
106
, 454-‐461(1996).
58 Meddeb-‐Garnaoui, A.; Toumi, A.; Ghelis, H.;Mahjoub,M.; Louzir, H.; Chenik,M. Cellular and
humoral responses induced by
Leishmania
histone H2B and its divergent and conserved
parts in cutaneous and visceral leishmaniasis patients, respectively. Vaccine
28
, 1881-‐
1886(2010).
59 deCarvalho, L. P.; Soto,M.; Jeronimo, S.; Dondji, B.; Bacellar, O.; Luz, V.; Orge, G.; Alonso, C.;
Jesus, A. R.; Carvalho, E. M. Characterization of the immune response to
Leishmania
infantum
recombinant antigens.Microbes and Infection
5
, 7-‐12(2003).
60 Iborra, S.; Soto; M.; Carrion, J.; Alonso, C.; Requena, J. M. Vaccinationwith a plasmid DNA
cocktail encoding the nucleosomal histones of
Leishmania
confers protection against
murinecutaneous leishmaniosis. Vaccine
22,
3865-‐3876(2004).
61 Carrion, J.; Nieto, A.; Soto, M.; Alonso, C. Adoptive transfer of dendritic cells pulsed with
Leishmania infantum
nucleosomal histones confers protection against cutaneous
leishmaniosis inBALB/cmice.Microbes and Infection
9
, 735-‐743(2007).
62 Carneiro, M. W.; Santos, D. M.; Fukutani, K. F.; Clarencio, J.; Miranda, J. C.; Brodskyn, C.;
Barral, A.; Barral-‐Netto, M.; Soto, M.; deOliveira, C. I. Vaccinationwith
L. infantumchagasi
nucleosomal histones confers protection against new world cutaneous leishmaniasis
causedby
Leishmaniabraziliensis
. PLoSOne.
7
, e52296(2012).
63 Carrion, J.; Folgueira, C.; Alonso, C. Immunization strategies against visceral leishmaniosis
with the nucleosomal histones of
Leishmania infantum
encoded inDNA vaccine or pulsed
indendritic cells. Vaccine
26
, 2537-‐44(2008).
64 Solioz, N.; Blum-‐Tirouvanziam, U.; Jacquet, R.; Rafati, S.; Corradin, G.; Mauel, J.; Fasel, N.
The protective capacities of histone H1 against experimental murine cutaneous
leishmaniasis. Vaccine.
18
, 850-‐859(1999).
65 Masina, S.; Gicheru, M. M.; Demotz, S. O.; Fasel, N. J. Protection against cutaneous
leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen. The
Journal of InfectiousDiseases.
188
, 1250-‐1257(2003).
66 Moreno, J.; Nieto, J.; Masina, S.; Cañavate, C.; Cruz, I.; Chicharro, C.; Carrillo, E.; Napp, S.;
Reymond, C.; Kaye, P. M.; Smith, D. F.; Fasel, N.; Alvar, J. Immunization with H1, HASPB1
andMML
Leishmania
proteins inavaccine trial against experimental canine leishmaniasis.
Vaccine
25
, 5290-‐5300(2007).
67 Coelho, E. A.; Ramirez, L.; Costa,M. A.; Coelho, V. T.;Martins, V. T.; Chavez-‐Fumagalli,M. A.;
Oliveira, D. M.; Tavares, C. A.; Bonay, P.; Nieto, C. G.; Abanades, D. R.; Alonso, C.; Soto, M.
Specific serodiagnosis of caninevisceral leishmaniasisusing
Leishmania
species ribosomal
proteinextracts. Clinical andVaccine Immunology
16
, 1774-‐1780(2009).
68 Ramirez, L.; Santos, D. M.; Souza, A. P.; Coelho, E. A.; Barral, A.; Alonso, C.; Escutia, M. R.;
Bonay, P.; de Oliveira, C. I.; Soto, M. Evaluation of immune responses and analysis of the
effect of vaccination of the
Leishmaniamajor
recombinant ribosomal proteins L3 or L5 in
twodifferentmurinemodelsof cutaneous leishmaniasis. Vaccine.
31
, 1312-‐1319(2013).
69 Soto, M.; Requena, J. M.; Quijada, L.; Angel, S. O.; Gomez, L. C.; Guzman, F.; Patarroyo, M. E.;
Alonso, C. During active viscerocutaneous leishmaniasis the anti-‐P2 humoral response is
specifically triggered by the parasite P proteins. Clinical and Experimental Immunology
100
, 246-‐252(1995).
